Stockscreener 앱 받기
82.33
1.25%
-1.04
전일 마감가:
$83.37
열려 있는:
$83.81
하루 거래량:
2.08M
Relative Volume:
0.88
시가총액:
$15.93B
수익:
$8.41B
순이익/손실:
$760.80M
주가수익비율:
21.38
EPS:
3.8513
순현금흐름:
$1.05B
1주 성능:
-0.69%
1개월 성능:
-11.48%
6개월 성능:
-6.97%
1년 성능:
-13.44%
1일 변동 폭
$82.04
$83.99
1주일 범위
$82.04
$84.50
52주 변동 폭
$79.83
$108.29
짐머 바이오메트 Stock (ZBH) Company Profile
명칭
Zimmer Biomet Holdings Inc
전화
(574) 267-6131
주소
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
82.33 | 15.93B | 8.41B | 760.80M | 1.05B | 3.8513 |
ABT
Abbott Laboratories
|
84.32 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
285.47 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
76.15 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.93 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
79.96 | 46.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
짐머 바이오메트 Stock (ZBH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-23 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2026-02-20 | 개시 | William Blair | Mkt Perform |
| 2026-01-09 | 다운그레이드 | Goldman | Neutral → Sell |
| 2026-01-06 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2026-01-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-12-16 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-09-18 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-07-15 | 업그레이드 | Roth Capital | Neutral → Buy |
| 2024-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-09-10 | 개시 | Wolfe Research | Peer Perform |
| 2024-07-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-21 | 업그레이드 | Argus | Hold → Buy |
| 2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-10-20 | 개시 | ROTH MKM | Neutral |
| 2023-08-28 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-05-03 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-04-11 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-03-31 | 업그레이드 | Jefferies | Underperform → Hold |
| 2023-03-29 | 개시 | UBS | Sell |
| 2023-03-10 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Underweight |
| 2022-10-12 | 개시 | Jefferies | Underperform |
| 2022-05-27 | 다운그레이드 | Needham | Buy → Hold |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2022-04-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-02 | 재개 | BofA Securities | Underperform |
| 2022-03-02 | 다운그레이드 | Loop Capital | Buy → Hold |
| 2022-02-08 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | 재확인 | Citigroup | Buy |
| 2022-02-08 | 재확인 | Deutsche Bank | Hold |
| 2022-02-08 | 재확인 | JMP Securities | Mkt Outperform |
| 2022-02-08 | 재확인 | JP Morgan | Neutral |
| 2022-02-08 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | 재확인 | Stifel | Buy |
| 2022-02-08 | 재확인 | Truist | Buy |
| 2022-02-08 | 재확인 | UBS | Neutral |
| 2022-02-08 | 재확인 | Wells Fargo | Underweight |
| 2022-02-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-01-19 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2021-12-07 | 개시 | Loop Capital | Buy |
| 2021-11-23 | 다운그레이드 | Argus | Buy → Hold |
| 2021-09-14 | 재개 | Raymond James | Mkt Perform |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-09 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-12-18 | 재확인 | Needham | Strong Buy |
| 2020-10-20 | 개시 | Northland Capital | Market Perform |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-08-05 | 재확인 | Needham | Strong Buy |
| 2020-04-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-04-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-04-07 | 재확인 | Needham | Strong Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2020-01-07 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2019-09-18 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | 업그레이드 | Argus | Hold → Buy |
| 2019-07-30 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2019-07-29 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | 업그레이드 | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | 업그레이드 | Needham | Buy → Strong Buy |
모두보기
짐머 바이오메트 주식(ZBH)의 최신 뉴스
Zimmer Biomet (NYSE:ZBH) Rating Increased to Buy at Wall Street Zen - MarketBeat
Zimmer Biomet Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Oak Family Advisors LLC Sells 37,733 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet to Present at the BofA Securities 2026 Health Care Conference - PR Newswire
Zimmer Biomet (ZBH) CAO awarded 9,232 RSUs vesting over three years - Stock Titan
How Zimmer Biomet Holdings Inc. (ZBH) Affects Rotational Strategy Timing - Stock Traders Daily
Why Zimmer Biomet (ZBH) is a Top Growth Stock for the Long-Term - Yahoo Finance
Zimmer Biomet (ZBH) Is Down 9.2% After Strong Q1, CFO Exit And Ongoing Buybacks – Has The Bull Case Changed? - Sahm
Robertson Stephens Wealth Management LLC Buys Shares of 12,539 Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating A Potential 18.85% Upside - DirectorsTalk Interviews
Zimmer Biomet Announces Chief Financial Officer Transition - Building Indiana Business
BofA Securities Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Maintains Target Price $100 - Moomoo
Zimmer Biomet Holdings 1Q 2026: Revenue $2.09B, EPS $1.22— 10-Q Summary - TradingView
Zimmer Biomet (NYSE: ZBH) posts Q1 2026 growth and updates 2026 view - Stock Titan
Zimmer Biomet Ordered to Defend Fraud Claim in Device Deal Case - Bloomberg Law News
Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results - Quantisnow
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock - Yahoo Finance
Results: Zimmer Biomet Holdings, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - simplywall.st
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Vanguard holds 7.54% of Zimmer Biomet (ZBH) via Schedule 13G filing - Stock Titan
Zimmer Biomet falls after CEO exit, unchanged growth outlook - MSN
Zimmer Biomet Stock (US98956P1021): Q3 2025 Earnings Beat Expectations with 5.2% Revenue Growth - AD HOC NEWS
A Look At Zimmer Biomet (ZBH) Valuation After CFO Exit And Solid Quarterly Results - Yahoo Finance
A Quick Look at Today's Ratings for Zimmer Biomet Holdings(ZBH.US), With a Forecast Between $83 to $105 - Moomoo
Zimmer Biomet Holdings (ZBH) Receives a Hold from Truist Financial - The Globe and Mail
RBC Capital Sticks to Their Buy Rating for Zimmer Biomet Holdings (ZBH) - The Globe and Mail
Vanguard Group Inc. Buys 192,517 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings Hits New 52-Week Low at $81.36 - Markets Mojo
Zimmer Biomet Buzz Grows Across NYSE Composite Trend - Kalkine Media
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Zimmer Biomet (NYSE:ZBH) Given New $95.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Zimmer Biomet Q1 2026 earnings preview - MSN
Zimmer Biomet Supported by Sales Force Improvements, 2026 Upside Potential, RBC Says - marketscreener.com
Zimmer Biomet (NYSE:ZBH) Price Target Cut to $105.00 by Analysts at Citizens Jmp - MarketBeat
Zimmer Biomet CFO Suketu Upadhyay to depart - MSN
Wells Fargo & Company Lowers Zimmer Biomet (NYSE:ZBH) Price Target to $90.00 - MarketBeat
Zimmer Biomet (NYSE:ZBH) Price Target Lowered to $105.00 at Stifel Nicolaus - MarketBeat
Zimmer Biomet's (ZBH) Hold Rating Reaffirmed at Truist Financial - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q1 2026 Earnings Call Transcript - Insider Monkey
JPMorgan Adjusts Price Target on Zimmer Biomet Holdings to $95 From $100, Maintains Neutral Rating - marketscreener.com
Citigroup Adjusts Price Target on Zimmer Biomet to $95 From $98, Maintains Neutral Rating - marketscreener.com
Baird Adjusts Price Target on Zimmer Biomet to $92 From $100, Maintains Neutral Rating - marketscreener.com
Zimmer Biomet net sales up 9.3% to USD 2.087B in Q1 2026 - Medical Buyer
Barclays Adjusts Price Target on Zimmer Biomet to $94 From $100, Maintains Underweight Rating - marketscreener.com
Goldman Sachs Adjusts Price Target on Zimmer Biomet to $86 From $89, Maintains Sell Rating - marketscreener.com
Wells Fargo Adjusts Price Target on Zimmer Biomet to $90 From $98, Maintains Equalweight Rating - marketscreener.com
Stifel Adjusts Price Target on Zimmer Biomet to $105 From $110, Maintains Buy Rating - marketscreener.com
Citizens cuts Zimmer Biomet stock price target on mixed results By Investing.com - Investing.com South Africa
Zimmer Biomet (NYSE:ZBH) Hits New 12-Month LowShould You Sell? - MarketBeat
Citizens cuts Zimmer Biomet stock price target on mixed results - Investing.com
Zimmer Biomet Holdings Inc (ZBH) Q1 2026 Earnings Call Highlights: Strong Start with 9.3% Revenue Growth - GuruFocus
짐머 바이오메트 (ZBH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.92%
0.18%
자본화:
|
볼륨(24시간):